A - agilent.com Operating profit EBITDA

Graphic logo of agilent.com (A)

Agilent Technologies' profit dependence on government science funding drives the actual operating profit dynamics on the GURU.Markets chart, where the current parameter is 2041.69. Rising demand for cancer diagnostics and recurring payments support the company's position. Simultaneously, the business is implementing AI platforms and automated dispensers to accelerate laboratory research.

Agilent Technologies (A): Operating profit EBITDA from 11/23/2025 to 11/10/2026

Agilent (A) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Market Chart Agilent Corp|A - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Agilent|A - Enterprise Value
- book value of equity indicators:
Book Value of One Share Agilent|A - Book Capitalization|Market Capitalization to Book Value agilent.com|A - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Equity Agilent Technologies|A - Long-Term Debt to Capital|Current Liabilities to Capital Agilent Technologies, Inc.|A - Company Debts|Debt to Book Value Ratio Agilent|A - Company Long-Term Liabilities|Amount of Current Liabilities Agilent|Intermediate Coverage Ratio agilent.com
- net income and valuation ratios data:
A - Net Income|Future Net Profit Agilent Technologies|A - P/E Multiple|Projected Price to Earnings Ratio agilent.com|A - PEG Multiple|Enterprise Value to EBITDA Ratio Agilent|A - Operating profit EBITDA|Earnings per share for the trailing year Agilent|A - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months agilent.com|A - Earnings per share growth in current year|Expected net earnings per share growth next year Agilent Technologies
Analysis of all company metrics:Agilent Corp - A
Manufactured products of Agilent Technologies

Agilent Technologies' dominance in the laboratory equipment sector and steady demand for consumables are clearly reflected in the dynamics of cash operating profit before deductions. This indicator captures the actual volume of cash generated by the core business prior to tax obligations. The calculation is based on the summation of operating income minus all variable and fixed costs. A stable upward trend confirms the high efficiency of the commercial model. For the investor, growth in this metric signifies resilience to competition and an absence of liquidity risks.

Competitor analysis for Agilent Technologies

Operating income before deduction of amortization Quest Corp (DGX)|Illumina, Inc. - Operating profit EBITDA|EXAS - Operating profit EBITDA|RVTY: Operating profit EBITDA|Operating profit before depreciation charges Bio-Rad Laboratories, Inc. BIO|NNNN (Anbio Tech) - Operating profit EBITDA|Nordion (SHC) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization QuidelOrtho (QDEL)|Profit before payment of interest, taxes and amortization OPK (opko.com)|Operating profit EBITDA CDNA (CareDx Inc)|Maravai LifeSciences Holdings (MRVI) - Profit before interest, taxes and amortization|FLGT - Profit before payment of interest, taxes and amortization|LAB (Standard BioTools Corp) - Operating profit before amortization|CTKB (Cytek Biosciences, Inc.) - Operating profit before deduction of amortization|OSUR: Company profit before taxes, interest and amortization|Operating profit before deduction of amortization XGN|MDXH: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization LUCD (Lucid Diagnostics Inc)|Company profit before taxes, interest and amortization PRE|Operating profit EBITDA IMDX (Insight Molecular Diagnostics Inc)|Trinity Biotech PLC (TRIB) - Profit before interest, taxes and amortization|ProPhase Labs - Operating profit EBITDA|Ainos Inc (AIMD) - Operating profit before deduction of amortization|CODX: Operating profit EBITDA|Heart Test Labs - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Biomerica, Inc.|Operating profit before amortization CDIO (Cardio Diagnostics Holdings, Inc.)|Profit before payment of interest, taxes and amortization Onconetix (ONCO)|VRAX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Bluejay BJDX|Aspira Women's Health Inc - Profit before payment of interest, taxes and amortization|AXDX - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Centogene|ENZ: Operating profit EBITDA|Operating profit before depreciation charges Fresh2 Group FRES|GENE (Genetic Technologies Ltd) - Operating profit EBITDA|23andMe Inc (ME) - Operating income before deduction of amortization|Operating profit EBITDA PMD